1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Stryker Corporation

Stryker Corporation

SYK.DE
Stryker CorporationDE flagDeutsche Börse
289.00
EUR
+3.05
- -
110.79BMarket Cap
Stryker Corporation
SYK.DE
(Deutsche Börse)

Recent

price

289.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
18.47
21.49
22.75
23.83
25.56
26.41
30.27
33.27
36.36
39.8
38.22
45.38
48.78
54
59.3
65.71
66.07
Revenue per Share
3.21
3.48
3.41
2.66
1.36
3.82
4.4
2.73
9.5
5.57
4.26
5.29
6.23
8.34
7.86
8.49
8.72
Basic EPS, GAAP
3.44
3.13
3.8
4.47
4.09
1.89
3.81
2.57
5.45
4.12
7.43
7.26
5.38
8.26
9.15
11.21
11.95
Free Cash Flow per Basic Share
0.6
0.72
0.85
1.06
1.22
1.38
1.52
1.7
1.88
2.08
2.3
2.52
2.78
3
3.2
3.36
3.4
Dividend per Share
15.28
16.86
19.36
20.22
20.07
20.79
23.73
24.13
28.87
31.51
33.29
35.86
39.14
44.28
48.73
53.66
54.68
Book Value per Share
13.62
10.79
13.22
8.49
6.32
6.85
-0.84
-1.78
-2.66
-1.31
-13.98
-7.64
-8.33
-3.27
1.01
-6.68
-4.51
Tangible Book Value per Share
396
386
381
379
378
377
374
374
374
374
376
377
378
380
381
382
382
Basic Weighted Avg Shares
7,320
8,307
8,657
9,021
9,675
9,946
11,325
12,444
13,601
14,884
14,351
17,108
18,449
20,498
22,595
25,116
25,270
Sales/Revenue/Turnover
25.61
21.21
22.12
20.82
20.74
21.69
20.6
19.85
18.82
19.52
15.61
15.71
16.86
19.14
20.65
20.14
20.27
Operating Margin (%)
223
282
277
307
378
397
546
642
723
778
812
990
998
1,028
1,050
1,193
1,221
Depreciation Expense
1,273
1,345
1,298
1,006
515
1,439
1,647
1,020
3,553
2,083
1,599
1,994
2,358
3,165
2,993
3,246
3,337
Net Income, GAAP
26.37
20.23
23.87
17
55.6
17.06
14.26
50.56
- -
18.7
18.17
12.58
12.11
13.83
14.29
28.09
27.46
Effective Tax Rate (%)
17.39
16.19
14.99
11.15
5.32
14.47
14.54
8.2
26.12
13.99
11.14
11.66
12.78
15.44
13.25
12.92
13.21
Profit Margin (%)
6,027
5,367
6,272
5,678
4,223
4,441
4,713
4,508
4,926
6,658
4,666
5,468
3,972
4,597
7,231
6,961
7,023
Working Capital
996
1,751
1,746
2,739
3,246
3,230
6,686
6,590
8,486
10,231
13,230
12,472
11,857
10,901
12,188
14,859
14,224
LT Debt
7,174
7,683
8,597
9,047
8,595
8,511
9,550
9,980
11,730
12,807
13,084
14,877
16,616
18,593
20,634
22,420
22,979
Total Equity
18.49
15.85
14.64
14.02
7.21
14.07
13.78
7.24
- -
10.34
7.17
8.61
9.56
10.98
12.05
9.96
9.77
Return on Invested Capital (%)
20.32
17.86
14.9
10.29
4.68
12.3
11.93
6.36
- -
9.57
6.48
7.6
8.76
12.06
10.79
10.75
9.66
Return on Capital (%)
22.15
21.4
18.69
13.39
6.75
18.66
19.72
11.4
35.84
18.44
13.17
15.33
16.65
20.02
16.92
16.61
16.76
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
1,750
1,000
499
LT Borrowings
14,845
14,859
14,224
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
382
382
383
Market Capitalization
141,870
134,703
125,480

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
13,711
14,755
13,338
Cash, Cash Equivalents & STI
3,343
4,100
2,965
Accounts Receivable, Net
3,643
4,039
3,571
Inventories
5,370
5,310
5,419
Total Current Liabilities
7,414
7,794
6,315
Payables & Accruals
4,358
5,199
4,931
ST Debt
1,750
1,000
499
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
10.25%
11.39%
8.66%
Free Cash Flow
29.71%
12.11%
22.83%
Net Income, GAAP
24.03%
16.04%
8.45%
Sales/Revenue/Turnover
9.84%
11.91%
11.16%
Total Cash Common Dividend
9.46%
8.29%
5.33%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
5,243
5,422
5,494
6,436
22,595
2025
5,866
6,022
6,057
7,171
25,116
2026
6,020
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2.07
2.17
2.19
1.43
7.86
2025
1.71
2.31
2.25
2.22
8.49
2026
1.95
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.8
0.8
0.8
0.8
3.2
2025
0.84
0.84
0.84
0.84
3.36
2026
0.88
- -
- -
- -
- -
Similar Companies
REMSleep Holdings, Inc. (RMSL)
T&L Co., Ltd. (340570.KQ)
Össur hf. (OSSR.CO)
Anteris Technologies Ltd (AVR.AX)
ReWalk Robotics Ltd. (RWLK)
Soliton, Inc. (SOLY)
Business
Stryker Corporation (NYSE: SYK) develops, manufactures and markets medical technologies for use in medical and surgical operations, orthopaedics and neurotechnology; products include reconstructive implants for hip, knee, shoulder, ankle, foot and spine, trauma and extremities systems, orthobiologics and biosurgery; medical and surgical equipment encompassing endoscopy systems, patient handling and emergency medical equipment, surgical power tools, computer-assisted surgery, minimally invasive solutions and intensive care disposables; neurotechnology and spine offerings such as neurosurgical instruments, neurovascular products, cranial and spinal implants, interventional spine devices; and services including equipment maintenance, reprocessing of single-use devices, financial options and customized workflow solutions. The company, founded in 1941 and headquartered in Kalamazoo, Michigan, sells its products through subsidiaries, branches and distributors to hospitals, doctors and healthcare facilities in approximately 75 countries. In 2024-2025, Stryker completed acquisitions of Webdr.ai, Vertos Medical, NICO Corporation and Inari Medical for $4.8 billion to strengthen capabilities in orthopaedics and spine, neurotechnology, corridor surgery and peripheral vascular thrombectomy; launched the Incompass Total Ankle System, Surpass Elite Flow Diverter and InThrill Thrombectomy System; and announced the sale of its U.S. spinal implants business.